Chinese economic performance in the first half analysis: production and distribution work together – Economic Operation – Filtration and Separation Industry
This year, our various industries to tackle the financial crisis in the process, efforts to overcome various difficulties and positive factors in economic operations increasing, the national economy is expected to continue moving in the direction of macro regulation and control, the overall trend showed the development of stabilizing and recovering . In the first half, GDP grew 7.10%, 1.0 percentage points than the first quarter accelerated. The overall macroeconomic environment stabilized by the State to good effect, medicine overall economic operation has steadily increased industrial production, commercial purchase and sales growth momentum of stable and effective level of the sound development of improved pattern.
Steady growth in business buying and selling
Growth in industrial production for medicine, but the rate has dropped. According to statistics, 1 May industrial output value of the national pharmaceutical industry (at current prices) completed the 365.1 billion yuan, up 17.90 percent over the same period the previous year. Data, the growth is still the basic pattern of development of the pharmaceutical industry. Situation from the industry classification, sanitary materials and medical supplies, Chinese Herbal Medicine, biological and biochemical products, chemicals to maintain a fast growth, the growth rate higher than the industry average.
Convergence of good marketing. 1 May, the pharmaceutical industry sales value of completed 345.8 billion yuan, up 16.74% over the same period the previous year, the pharmaceutical industry sales rate of 94.91 percent, essentially flat with a year earlier.
Active consumer demand. According to statistics, 1 in June, all seven major categories of Traditional Chinese Medicine to 192.6 billion yuan worth of goods purchased, up 10.74 percent over the same period the previous year. One class of drugs purchased for the 147.2 billion yuan, up 11.85 percent over the same period the previous year; proprietary class purchased 317 billion yuan, up 8.03% over the same period; medical equipment purchased for the class of 2.4 billion, compared with a year earlier 1.27% increase. The value of total sales of 213.7 billion yuan, a year earlier than the previous year growth of 11.66%, net sales of 121 billion yuan, up 7.41% over the same period the previous year, of which class of drugs was 162.5 billion yuan of total sales, up 13.38 over the same period the previous year %, net sales of 90.5 billion yuan, up 7.72% over the same period the previous year; proprietary class of the total sales of 350 billion yuan, up 7.39% over the same period, net sales of 212 billion yuan, up 7.68% over the same period, The total sales of medical equipment class is 27 billion yuan, up 2.59% over the same period, net sales of 1.8 billion, essentially flat with a year earlier. From the regional distribution, the country's 30 provinces, municipalities, district sales growth of 27 over the same period, accounting for 90%. Which increased by more than the national average of 10, accounting for 37% growth in the region. The top area sales were Shanghai, Beijing, Zhejiang, Guangdong, Jiangsu, Anhui, six provinces (municipalities) sales accounting for 62% of sales, its share rose 2 percentage points.
Overall stabilization of the level of pharmaceutical business benefits. According to statistics, in 2008 industry profit margin of 1.18%, gross margin was 7.07%, 6.45% fee. From the business point of view, the first 20 hundred enterprises together account for industry profits, profit 57.14%, 37.46% of them occupy the top 10.
Good external environment for Chinese Medicine
The first half of this year, implementation of national macroeconomic policies, to the pharmaceutical industry to provide a favorable external environment, medicine and industry experienced an unprecedented opportunity for development, the main features are the following:
First, stabilize macro-economic development has become more evident to the momentum for reform and development of the pharmaceutical industry provides a good external environment. In the international financial crisis continue to spread and deepen the context of the fourth quarter of last year, the state introduced further measures to expand domestic demand of 10, another massive increase in expenditure this year, great efforts to strengthen financial support to economic development and investment, consumption , foreign trade, social security and so introduced a series of policy measures to create a systematic and comprehensive response to the crisis and maintain steady and rapid economic development package. Stabilizing the national economy recovered, the economic and social development to achieve the main target. Sound macroeconomic environment for the reform and development of the pharmaceutical industry has laid a solid foundation.
Second, Chinese economy has maintained steady growth momentum of development. This year, local pharmaceutical companies closely around the two major goals of reform and development, new medical reform policy to seize the opportunities for industry to continuously accelerate institutional innovation, technological innovation and management innovation, accelerate the pace of reform and restructuring of property rights system, and promote the business production and operation of the continuous improvement of competitiveness, and promote the improvement of economic efficiency of enterprises, the pharmaceutical industry's contribution to macroeconomic growth to further improve.
Third, mergers and acquisitions, restructuring promoted the restructuring of the field of medicine distribution.
I am a professional writer from Chinese Manufacturers, which contains a great deal of information about $keyword_li, welcome to visit!
Processing your request, Please wait....
